Key result
In patients with calcific aortic valve disease, miR-21-5p was significantly increased (P<0.0001) and TGFBI was decreased (P<0.01) in calcified valves compared to paired normal tissues.
Why the study?
The key factors and mechanisms mediating valve mineralization in CAVD remain unclear, prompting investigation into the role of miRNAs and their downstream targets in disease progression.
Does miR-21-5p promote osteogenic differentiation and calcification of valvular interstitial cells by targeting TGFBI in calcific aortic valve disease?
Observational (n=15)
No
Does miR-21-5p promote osteogenic differentiation and calcification of valvular interstitial cells by targeting TGFBI in calcific aortic valve disease?
p-value: p=<0.0001
miR-21-5p promotes osteogenic differentiation and calcification of valvular interstitial cells by targeting TGFBI, suggesting a potential therapeutic target for calcific aortic valve disease.
Background: Calcific aortic valve disease (CAVD) is the most common heart relating disease with high morbidity and mortality, especially in elderly population. While extensive investigations have been devoted to the study of mechanistic pathways related to CAVD, the key factors and mechanisms mediating valve mineralization remain unclear. The aim of this study is to investigate the role of mirnas and their downstream targets in CAVD disease progression. A previous recent multi-omics study suggested a novel CAVD molecular interaction network contained miR-21-5p. Methods: CAV and their pair-matched adjacent normal tissues were obtained from 15 patients pathologically diagnosed as CAVD and admitted in Yancheng Third People's Hospital (The Sixth Affiliated Hospital of Nantong University) from 2019-2021. RT-qPCR was utilized for detection of miR-21-5p and related protein expression levels to confirm the related factors in CAVD progression. Western blotting was applied to strengthen the results of RT-qPCR and confirm osteogenic differentiation of VICs via biomarker detection. The staining of alkaline phosphatase (ALP) and alizarin red was performed to assess the degree of VIC mineralization. Results: We found that miR-21-5p was remarkably increased (P<0.0001) in calcified aortic valves (AVs) whereas TGFBI was diminished (P<0.01) in CAVD samples compared to the paired normal tissues from CAVD patients. Additionally, TGFBI was targeted by miR-21-5p. Furthermore, overexpressing TGFBI could block VIC osteogenic differentiation mediated by miR-21-5p. To sum up, miR-21-5p promotes VIC osteogenic differentiation and calcification via TGFBI in CAVD progression. Conclusion: Our work might bring a sight on underlying mechanisms of CAVD progression and provide a possible therapeutic target for diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2024) conducted an observational in Calcific aortic valve disease (CAVD) (n=15). Calcified aortic valve tissue vs. Paired adjacent normal tissue was evaluated on miR-21-5p and TGFBI expression levels (p=<0.0001). In patients with calcific aortic valve disease, miR-21-5p was significantly increased (P<0.0001) and TGFBI was decreased (P<0.01) in calcified valves compared to paired normal tissues.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: